Please login to the form below

Not currently logged in
Email:
Password:

Icon appoints Hugh Brady to board

He is former president of University College Dublin
ICON Hugh Brady

The contract research organisation (CRO) ICON has appointed Dr Hugh Brady to its board of directors.

Dr Brady is former president of University College Dublin (UCD) in Ireland, where he served from 2004 to 2013.

During this time he oversaw the expansion of the University's science, engineering and biomedical research capacity, including the development of several new research centres.

He also built links across the world, establishing the Beijing-Dublin International College and the UCD Shenzhen Health Sciences Institute in China.

In his role at Icon Dr Brady will be able to offer an in-depth knowledge of academia and research networks to Icon's efforts to support the pharma, biotech and medical device industries.

Thomas Lynch, chairman of Icon said: “His inspirational leadership of UCD, Irelands' largest university, during the past ten years, extensive international experience, especially in Asia, coupled with a distinguished career as an academic clinician in Ireland and the US will bring invaluable experience and expertise to Icon.”

2nd May 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....

Infographics